Acute Effect of Passive Joint Mobilization in Non-Specific Neck Pain
Neck Pain
About this trial
This is an interventional treatment trial for Neck Pain focused on measuring non-specific neck pain, passive joint mobilization, blood markers, neck range of motion
Eligibility Criteria
Inclusion Criteria:
For Intervention Group;
- Having neck pain lasting more than 30 days and being diagnosed with non-specific neck pain
- Having obtained 14/50 points and above in Neck Disability Index
- Expressing neck pain at least 34/100 points and above on a Visual Analog Scale
- Being 20-45 years old and female
For Healthy Control Group;
- Healthy volunteers without a chronic illness and musculoskeletal pain
Exclusion Criteria:
- Congenital anomalies
- Previously diagnosed orthopedic diseases related to the spine
- Pregnancy and having just given birth
- Within the last 3 months; use of corticosteroids, cytotoxic drugs, or immunosuppressants
- Liver or kidney failure
- Acute or chronic infections (including HIV)
- Serious pathologies (such as cancer, spondylolisthesis, rheumatoid arthritis or ankylosing spondylitis)
- Symptoms of cervical spinal stenosis (such as incoordination of hands, arms and legs, bowel and bladder incontinence)
- Radix compression (such as sensory changes, muscle weakness or decreased reflexes)
- Whiplash or a history of cervical surgery
Sites / Locations
- Pamukkale University School of Physical Therapy and Rehabilitation
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention Group
Healthy Control Group
24 female participants with non-specific neck pain included in the mobilization group will undergo detailed manual cervical examination. In the evaluation, the most painful segment with dysfunction will be selected and mobilization application and algometric measurements will be performed on this segment. Grade 3 Central Posterior-Anterior (CPA) passive joint mobilization with Maitland method will be applied in 3 sets, 30 seconds, to the segment with the detected dysfunction.
Healthy volunteer participants included in the control group will only be applied an evaluation protocol and blood samples will be taken without any application.